Full metadata record

DC Field Value Language
dc.contributor.authorUm, JY-
dc.contributor.authorChung, HS-
dc.contributor.authorKim, KS-
dc.contributor.authorKwon, IC-
dc.contributor.authorJeong, SY-
dc.date.accessioned2024-01-21T09:10:04Z-
dc.date.available2024-01-21T09:10:04Z-
dc.date.created2021-09-03-
dc.date.issued2003-03-06-
dc.identifier.issn0378-5173-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/138745-
dc.description.abstractA precursor type oily liquid formulation comprising monoolein, Pluronic F-127 and ethanol has been prepared as a carrier for lipophilic drugs. When dispersed in water, the liquid precursor formulation produces sub-micron (200-500 nm) sized lipid particles, named 'nanocubicles'. The interaction between nanocubicles and Caco-2 cell was studied, and the absorption of nanocubicles by cells was observed by various microscopic techniques. Lipid droplets were observed in cytosol after incubation with nanocubicles with time. The degree of pyrene absorption encapsulated in nanocubicles was dependent on particle size and incubation time. The amount of pyrene absorbed by Caco-2 cells was ca. 20% of total at 37 degreesC after an 8-h incubation. When nanocubicles with a bigger average particle size (ca. 600 nm) were applied, the uptake rate was reduced to 10% under identical experimental conditions. The nanocubicles were easily solubilized by bile salts to produce mixed micelles. As bile salt concentration increased, pyrene absorption into the jejunum of rat everted sac in vitro increased. (C) 2002 Elsevier Science B.V. All rights reserved.-
dc.languageEnglish-
dc.publisherELSEVIER SCIENCE BV-
dc.subjectSUBMICRON PARTICLES-
dc.subjectDELIVERY-
dc.subjectDRUG-
dc.subjectBIOAVAILABILITY-
dc.subjectCYCLOSPORINE-
dc.subjectMICROSCOPY-
dc.subjectLIPOSOMES-
dc.subjectSYSTEM-
dc.subjectCELLS-
dc.subjectRATS-
dc.titleIn vitro cellular interaction and absorption of dispersed cubic particles-
dc.typeArticle-
dc.identifier.doi10.1016/S0378-5173(02)00673-7-
dc.description.journalClass1-
dc.identifier.bibliographicCitationINTERNATIONAL JOURNAL OF PHARMACEUTICS, v.253, no.1-2, pp.71 - 80-
dc.citation.titleINTERNATIONAL JOURNAL OF PHARMACEUTICS-
dc.citation.volume253-
dc.citation.number1-2-
dc.citation.startPage71-
dc.citation.endPage80-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.identifier.wosid000181533300007-
dc.identifier.scopusid2-s2.0-0037422374-
dc.relation.journalWebOfScienceCategoryPharmacology & Pharmacy-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.type.docTypeArticle-
dc.subject.keywordPlusSUBMICRON PARTICLES-
dc.subject.keywordPlusDELIVERY-
dc.subject.keywordPlusDRUG-
dc.subject.keywordPlusBIOAVAILABILITY-
dc.subject.keywordPlusCYCLOSPORINE-
dc.subject.keywordPlusMICROSCOPY-
dc.subject.keywordPlusLIPOSOMES-
dc.subject.keywordPlusSYSTEM-
dc.subject.keywordPlusCELLS-
dc.subject.keywordPlusRATS-
dc.subject.keywordAuthorlipid-based drug delivery-
dc.subject.keywordAuthornanocubicle-
dc.subject.keywordAuthorcubic phase-
dc.subject.keywordAuthorCaco-2 cell-
dc.subject.keywordAuthoreverted sac-
dc.subject.keywordAuthorbile salt-
Appears in Collections:
KIST Article > 2003
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE